| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |